Protecting Egg Donors and Human Embryos—The Failure of the South Korean Bioethics and Biosafety Act by Jhalani, Mukta
Washington International Law Journal 
Volume 17 Number 3 
6-1-2008 
Protecting Egg Donors and Human Embryos—The Failure of the 
South Korean Bioethics and Biosafety Act 
Mukta Jhalani 
Follow this and additional works at: https://digitalcommons.law.uw.edu/wilj 
 Part of the Comparative and Foreign Law Commons, and the Health Law and Policy Commons 
Recommended Citation 
Mukta Jhalani, Comment, Protecting Egg Donors and Human Embryos—The Failure of the South Korean 
Bioethics and Biosafety Act, 17 Pac. Rim L & Pol'y J. 707 (2008). 
Available at: https://digitalcommons.law.uw.edu/wilj/vol17/iss3/6 
This Comment is brought to you for free and open access by the Law Reviews and Journals at UW Law Digital 
Commons. It has been accepted for inclusion in Washington International Law Journal by an authorized editor of UW 
Law Digital Commons. For more information, please contact cnyberg@uw.edu. 
Copyright © 2008 Pacific Rim Law & Policy Journal Association 
 
PROTECTING EGG DONORS AND HUMAN EMBRYOS—
THE FAILURE OF THE SOUTH KOREAN BIOETHICS 
AND BIOSAFETY ACT 
Mukta Jhalani† 
Abstract: Human embryonic stem cells have the potential to treat many physical 
and neurological disorders due to their unique ability to transform into any type of human 
cell.  The process of deriving stem cells from human embryos, however, raises important 
ethical and regulatory issues.  Embryonic stem cell research requires a steady source of 
human eggs to create embryos that are destroyed during stem cell extraction.  
International declarations and guidelines protect the two most vulnerable participants of 
embryonic stem cell research:  women who donate eggs for research purposes and human 
embryos that are destroyed in the research. 
In 2005, South Korea passed the Bioethics and Biosafety Act to regulate 
biotechnology research.  In its current form, the Bioethics and Biosafety Act fails to 
adequately protect egg donors and human embryos.  The Bioethics and Biosafety Act 
does not have adequate safeguards to protect egg donors, such as a requirement of 
voluntary consent and a requirement that egg donors understand the research and its 
potential risks.  The Institutional Review Boards established by the Bioethics and 
Biosafety Act are not sufficiently removed from the research institution to guarantee that 
egg donors are not exploited.  Additionally, this legislation fails to appropriately regulate 
the use of human embryos in scientific research as required by international guidelines.  
The Bioethics and Biosafety Act should include more detailed provisions dealing with the 
adequacy and quality of informed consent that is obtained from egg donors.  
Furthermore, Korea should amend its law to limit the use of human embryos in stem cell 
research so that the embryos are not unnecessarily destroyed. 
I. INTRODUCTION 
To realize its goal of becoming the “world-best science nation,” the 
Republic of Korea (“Korea”) is investing tremendous money and resources 
into scientific research and development.1  Embryonic stem cell research is 
one specific area of study that the Korean government has encouraged and 
supported.  In May 2006, the Korean government decided to invest 430 
billion won,2 or $454 million, into stem cell research over the next decade.3  
                                           
†
 Juris Doctor expected in 2009, University of Washington School of Law.  The author would like 
to thank Professor Sean O’Connor and the editorial staff at the Pacific Rim Law and Policy Journal for 
their guidance and assistance throughout the writing process.  The author would also like to thank her 
family and close friends for their support and patience. 
1
 Korea Gears Up Efforts to Become Science Leader, KOREA.NET, Dec. 20, 2007, 
http://www.korea.net (search for “Korea gears up efforts to become science leader”) (last visited Apr. 26, 
2008). 
2
 Won is the official currency of South Korea.  Central Intelligence Agency: The World Factbook, 
South Korea, https://www.cia.gov/library/publications/the-world-factbook/geos/ks.html (last visited Apr. 
26, 2008). 
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The money was allocated to support research on adult and embryonic stem 
cells as well as to strengthen the ethical infrastructure underlying stem cell 
research.4  Korea’s strong support for stem cell research has required it to 
pass new legislation to guide this innovative, yet controversial, field.  In 
2003, Korea passed the Bioethics and Biosafety Act (“Bioethics Act”) to 
deal with advances in biotechnology, particularly in stem cell research.5  The 
Bioethics Act came into effect at the beginning of 2005.6 
No binding international standards currently govern embryonic stem 
cell research.  In 1998, the United Nations (“UN”) passed a resolution 
banning all forms of human cloning that are “incompatible with human 
dignity and the protection of human life.”7  However, it is a non-binding 
declaration that was voted against by thirty-four member countries.8  Korea 
voted against the UN resolution and the Korean representative to the UN 
General Assembly made it clear that the resolution will not affect Korea’s 
policy of allowing therapeutic cloning.9  As a result, the Korean Bioethics 
Act allows therapeutic cloning, yet places a ban on reproductive cloning.10  
Reproductive cloning creates an embryo with the aim of producing a new, 
genetically identical individual, whereas therapeutic cloning produces 
embryos to be used in research.11  Thus, unlike reproductive cloning, 
therapeutic cloning has the potential to help patients by replacing or 
supplementing their damaged cells, tissues, or organs.12 
Korea’s continued support of therapeutic cloning and embryonic stem 
cell research arguably requires changes in the Bioethics Act to adequately 
protect egg donors and human embryos from exploitation and to bring the 
Act into compliance with international standards.  Part II of this Comment 
provides a brief introduction to the Bioethics Act and addresses the highly 
                                                                                                                              
3
 Government to Spend $450 Million on Stem Cell Research, KOREA.NET, May 30, 2006, 
http://www.korea.net (search for “Government to spend 450 million on stem cell research”) (last visited 
Apr. 26, 2008). 
4
 Id. 
5
 UN JONG PAK, BIOETHICS, RESEARCH ETHICS, AND REGULATION 203 (Seoul National University 
Press 2005). 
6
 Bioethics and Biosafety Act, Law No. 7150 of 2005 (an unofficial English translation), available 
at www.ruhr-uni-bochum.de/kbe/Bioethics&BiosafetyAct-SouthKorea-v1.0.pdf [hereinafter Bioethics 
Act]. 
7
 Declaration on Human Cloning, G.A. Res. 59/280, U.N. Doc. A/RES/59/280 (Mar. 23, 2005). 
8
 U.N. GAOR, 59th Sess., 82nd plen. mtg. at 5, U.N. Doc. A/59/PV.82 (Mar. 8, 2005). 
9
 Id.  See Korea: Korea to Continue Cloning Research, TODAY’S STEM CELL RESEARCH, Feb. 21, 
2005, http://www.stemnews.com/archives/000362.html (last visited Apr. 26, 2008). 
10
 See Bioethics Act, supra note 6, art. 11. 
11
 Human Genome Project Information, Cloning Fact Sheet, http://www.ornl.gov/sci/techresources/ 
Human_Genome/elsi/cloning.shtml (last visited Apr.26. 2008). 
12
 Alan Colman & Alexander Kind, Therapeutic Cloning: Concepts and Practicalities, 18 TRENDS IN 
BIOTECHNOLOGY 192, 192 (2000). 
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publicized stem cell research scandal that took place in Korea after the 
Bioethics Act became law.  Part III argues that the Bioethics Act falls short 
of international guidelines, such as the Declaration of Helsinki and the 
Nuremberg Code, because it does not require voluntary informed consent or 
comprehension of the research by egg donors.  Additionally, the institutional 
review boards (“IRB”) lack the independence necessary to monitor the 
quality of informed consent obtained.  Part IV raises questions about a 
human embryo’s status as a potential human being and argues that Korea’s 
legislation fails to protect human embryos by not limiting their use in 
embryonic stem cell research.  Part V recommends several approaches to 
strengthen the protections for human research subjects and place limitations 
on the use of human embryos in stem cell research.  This Comment 
ultimately concludes that Korea should make the necessary changes to the 
Bioethics Act to stay consistent with international standards and ensure that 
scientists are conducting ethical and legal research. 
II. JUST TWO YEARS AFTER THE BIOETHICS ACT CAME INTO EFFECT, 
KOREA RECOGNIZED THE NEED TO AMEND IT 
After several unsuccessful attempts, Korea finally passed the 
Bioethics Act on December 29, 2003; it became effective on January 1, 
2005.13  The Bioethics Act aims to promote biotech research that can be 
“used to prevent or cure human diseases.”14  The Bioethics Act allows 
scientists to conduct research on human embryos, but prohibits the 
production of embryos for purposes other than pregnancy.15  The uncovering 
of Korea’s infamous stem cell research scandal attracted the world’s 
attention to the regulation of embryonic stem cell research in Korea.  The 
scandal prompted the Korean government to examine the effectiveness of 
the Bioethics Act in preventing future ethical breaches by scientists and 
protecting research subjects who participate in embryonic stem cell 
research.16 
                                           
13
 PAK, supra note 5, at 203. 
14
 Bioethics Act, supra note 6, art. 1. 
15
 Bioethics Act, supra note 6, art. 13. 
16
 See Kim Tae-gyu, Korea Mulls Allowing Research Using Cloned Embryos, KOREA TIMES, Jan. 
20, 2007. 
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A. The Legislative History of the Bioethics Act Sheds Light on the 
Struggles in Drafting a Bioethics Act that Promotes Scientific 
Research and Protects Human Dignity 
Between 1997 and 2003, Korea attempted to legislate a bioethics law 
twelve times.17  In 2000, Korea’s Ministry of Science and Technology 
(“MOST”) formed the Korean Bioethics Advisory Commission (“KBAC”) 
to draft the first version of a bioethics law.18  KBAC completed and 
submitted the framework for the Basic Law on Bioethics to MOST.19  
KBAC recommended prohibiting both reproductive and therapeutic 
cloning.20  This commission also suggested temporarily allowing stem cell 
research on surplus frozen embryos from in vitro fertilization (“IVF”).21  
MOST was not satisfied with these recommendations and did not submit its 
version of the bioethics law to the Korean National Assembly.22 
Instead, in May 2002, MOST proposed the Bill on the Prohibition of 
Human Cloning and Stem Cell Research.23  Another government ministry, 
the Ministry of Health and Welfare (“MHW”), also took up the issue of 
drafting the bioethics bill.24  In contrast to MOST’s bill, which sought to 
foster research and development of biotechnologies, MHW’s bill focused on 
the issues of human dignity and safety.25  To consolidate the bills proposed 
by the two governmental ministries, MHW formulated the Act on Bioethics 
and Safety in July 2002.26  An associated gathering of citizen groups made 
changes to MHW’s Act on Bioethics and Safety and drafted its own bill 
entitled “Bioethics and Biosafety Act,” which amended the MHW bill.27  
The changes made by the citizen groups included complete prohibition of 
embryonic cloning and interspecies hybridization, as well as elevation of the 
National Bioethics Committee’s status and function.28  The government 
                                           
17
 Sung-Goo Han, Young Je Yoo & Wha-Joon Rho, New Cloning Technologies and Bioethics 
Issues: The Legislative Process in Korea, 13 EUBIOS J. ASIAN & INT’L BIOETHICS 205, 216 (2003). 
18
 Sang-yong Song, The Rise and Fall of Embryonic Stem Cell Research in Korea, ASIAN 
BIOTECHNOLOGY & DEV. REV., Nov. 2006, at 65, 66. 
19
 Id. 
20
 Id. 
21
 Id.  For a discussion of in vitro fertilization, see COLUMBIA ENCYCLOPEDIA (6th ed. 2007), 
available at http://www.encyclopedia.com/doc/1E1-invitro.html. 
22
 Song, supra note 18, at 66. 
23
 PAK, supra note 5, at 192. 
24
 Id. 
25
 Kim Mikyung, An Overview of the Regulation and Patentability of Human Cloning and 
Embryonic Stem Cell Research in the United States and Anti-Cloning Legislation in South Korea, 21 
SANTA CLARA COMPUTER & HIGH TECH. L. J. 645, 684 (2005). 
26
 Id. at 684-85. 
27
 Id. at 685-86. 
28
 Id. 
JUNE 2008           FAILURE OF THE SOUTH KOREAN BIOETHICS AND BIOSAFETY ACT 711 
  
reviewed the bills and finally produced a single bill to be considered by the 
National Assembly.29  After a year-long discussion, on October 14, 2003, the 
government bill, “Bioethics and Biosafety Act,” was referred to the Korean 
National Assembly, the assembly that ultimately passed the Bioethics Act in 
December 2003.30 
B. The Bioethics Act Establishes an Ethics Committee and Creates the 
Requirement of IRBs to Oversee Embryonic Stem Cell Research 
Although some of its provisions became applicable in 2003, the 
Bioethics Act did not take effect until January 1, 2005.31  In March 2004, 
MHW established the Bioethics and Biosafety Task Force Team (“Task 
Force Team”), which was entrusted with the responsibility to “provide an 
institutional framework on stem-cell research in order to ensure its 
transparency and ethical integrity.”32  The Task Force Team was also 
responsible for establishing and running the National Bioethics Committee 
(“NBC”),33 the reviewing body responsible under the Bioethics Act for 
overseeing bioethics and safety in the life sciences and biotechnologies.34 
The Bioethics Act stipulates a ten-member NBC, made up of 
scientists, ethicists, and government officials, to monitor any requested 
research on human embryos for a period of ninety days after receiving the 
request.35  Other important provisions of the Act include the following:  
creation of IRBs,36 a total ban on human cloning,37 a ban on embryonic 
cloning using somatic cell nuclear transfer (“SCNT”) except where the 
Committee permits such research,38 and conditions and criteria for utilizing 
embryos in scientific research.39 
                                           
29
 Id. at 686. 
30
 Id. 
31
 See Bioethics Act, supra note 6. 
32
 Press Release, Ministry of Health and Welfare, Bioethics and Safety Task Force Team Has Been 
Launched (Mar. 4, 2004), http://english.mohw.go.kr/ (search for “Bioethics and Safety Task Force Team”) 
(last visited Apr. 26, 2008). 
33
 Id. 
34
 Bioethics Act, supra note 6, art. 6. 
35
 Korea Okays Stem Cell Research, KOREA TIMES, Aug. 1, 2005. 
36
 Bioethics Act, supra note 6, art. 9. 
37
 Id. art. 11. 
38
 Id. art. 22. 
39
 Id. arts. 11-21. 
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C. The Hwang Embryonic Stem Cell Research Scandal and the 
Circumstances Surrounding It Attracted International Attention 
Under the newly enacted Bioethics Act, MHW approved the stem cell 
research that Professor Hwang Woo-Suk had started at the Seoul National 
University before the Bioethics Act came into effect.40  Less than four 
months after the Bioethics Act came into effect, Professor Hwang announced 
that he had made a breakthrough invention in stem cell research.  In May 
2005, Professor Hwang announced that his lab had been able to create 
eleven human embryonic stem cell lines that were patient-specific.41  This 
was the second major invention in less than one year made in Professor 
Hwang’s lab.42  Just one year prior, in 2004, Professor Hwang had 
announced that his team was able to create a stem cell line from a cloned 
human embryo.43  The Korean government had reacted to this news by 
issuing a stamp commemorating Professor Hwang’s achievements44 and 
investing millions of dollars in his research lab.45 
Some commentators have argued that under the strict requirements of 
the Bioethics Act, only Professor Hwang was eligible to conduct stem cell 
research at the time the Bioethics Act came into effect;46 the Additional 
Provisions of the Act allowed someone who was engaged in embryonic stem 
cell research prior to January 2005 to continue his research only if he had 
worked in the field for more than three years or had published a paper in an 
international journal.47  This provision allowed Professor Hwang, who had 
published his 2004 scientific results in Science,48 to continue his work on 
embryonic stem cell research uninterrupted, even after the Bioethics Act 
came into effect.  Although MHW allowed Professor Hwang to continue his 
                                           
40
 Korea Okays Stem Cell Research, supra note 35. 
41
 Erika Check, Korea’s Accelerating Stem-cell Work Prompts Calls for Global Ethical Rules, 435 
NATURE 393 (2005).  Patient-specific stem cells are created by taking genetic material from the patient 
such that the resulting cells are a perfect match for the patient and there are no problems of rejection.  Stem 
Cells Tailored to Patients, BBC NEWS, May 20, 2005, http://news.bbc.co.uk/2/hi/health/4555023.stm (last 
visited Mar. 16, 2008). 
42
 Chris Mason, The Korean Stem Cell Fiasco: Shifting the Focus, MEDICAL DEVICE TECHNOLOGY, 
Mar. 2006, at 24, 24, available at http://www.devicelink.com/mdt/archive/06/03/002.html. 
43
 Id. 
44
 S. Korea Takes Lead in Stem Cell Research, NEWSDAY.COM, May 20, 2005, 
http://www.newsday.com/news/health/ny-hsclon0521,0,2813316.story (last visited Apr. 17, 2008). 
45
 See Susan Watts, South Korea’s Cloning Controversy, BBC NEWS, July 11, 2006, 
http://news.bbc.co.uk/2/hi/programmes/newsnight/4602490.stm (last visited Feb. 17, 2008). 
46
 Tae-gyu, supra note 16. 
47
 Id.; Bioethics Act, supra note 6, Additional Provisions. 
48
 Tae-gyu, supra note 16. 
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work on stem cells, it did not approve any other scientist’s stem cell research 
project under the Bioethics Act until August 2005.49 
After the successes in embryonic stem cell research reported by 
Professor Hwang and endorsed by the Korean government, the entire world 
was shocked to hear that Professor Hwang’s research data had been 
fabricated.50  In his 2004 and 2005 papers, Professor Hwang fabricated 
results and manipulated photographs to claim that he had cloned the first 
human embryo and had derived patient-specific stem cells from cloned 
embryos.51  By January 2006, a committee at Seoul National University had 
confirmed that the data reported by Professor Hwang in his 2004 and 2005 
papers were fabricated.52  Several other reports of ethical violations were 
also brought against Professor Hwang,53 and he finally admitted in 
November 2005 that two of his research assistants had donated eggs for his 
research on embryonic stem cells and he had paid other egg donors for their 
donations.54 
The knowledge that Professor Hwang’s research was doctored created 
an uproar in the scientific community.55  Public faith in embryonic stem cell 
research decreased as a result of the scandal.56  The ethical irregularities of 
the Hwang scandal can be used as “ammunition [by] activists who are 
opposed to the technology on moral grounds.”57  Following the news of the 
scandal, the stock prices in the Korean biotech industry fell dramatically, and 
the news shook the whole biotech industry.58 
                                           
49
 Korea Okays Stem Cell Research, supra note 35. 
50
 Steve Connor, Inquiry Finds Korea’s Human Cloning Was All Fraud, INDEPENDENT (London), 
Jan. 11, 2006, at 25. 
51
 Id. 
52
 Dennis Normile, Gretchen Vogel & Jennifer Couzin, South Korean Team’s Remaining Human 
Stem Cell Claim Demolished, SCIENCE, Jan. 13, 2006, at 156, available at 
http://www.sciencemag.org/cgi/reprint/311/5758/156.pdf. 
53
 See generally Sei Chong, Investigations Document Still More Problems for Stem Cell 
Researchers, SCIENCE, Feb. 10, 2006, at 754, available at http://www.sciencemag.org/cgi/reprint/311/ 
5762/754.pdf (referring to reports stating that Hwang violated ethical principles in his collection of human 
oocytes and that the government auditor “could not account for $2.6 million in research funds that Hwang 
had received”). 
54
 Constance Holden, Korean Cloner Admits Lying About Oocyte Donations, SCIENCE, Dec. 2, 2005, 
at 1402, available at http://www.sciencemag.org/cgi/reprint/310/5753/1402.pdf. 
55
 See Lawrence K. Altman & William J. Broad, Global Trend: More Science, More Fraud, N.Y. 
TIMES, Dec. 20, 2005, at F5, available at http://www.nytimes.com/2005/12/20/science/20rese.html? 
pagewanted=print. 
56
 Paul Elias & Malcolm Ritter, Science Fraud Shakes Stem Cell Field, LIVESCIENCE, Dec. 24, 2005, 
http://www.livescience.com/strangenews/ap_051224_stem_cells.html (last visited Apr. 28, 2008). 
57
 See David Cyranoski, Korea’s Stem-Cell Stars Dogged by Suspicion of Ethical Breach, 429 
NATURE 3 (2004), available at http://www.nature.com/nature/journal/v429/n6987/pdf/429003a.pdf. 
58
 See Ichiko Fuyuno, Hwang Scandal Hits Korean Biotech Hard, 439 NATURE 265 (2006), available 
at http://www.nature.com/nature/journal/v439/n7074/pdf/439265a.pdf. 
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D. Korea Recognized the Need to Amend the Bioethics Act in the 
Aftermath of the Hwang Scandal 
After the Hwang scandal, Korea practically prohibited research on 
cloned human embryos.59  Then, in January 2007, NBC began to reconsider 
whether to allow research on cloned human embryos.60  NBC recognized 
that if it permitted this research, the government would have to revise bills to 
qualify more local institutions to get involved in embryonic cloning 
research.61  In March 2007, NBC lifted the ban on embryonic stem cell 
research on the condition that scientists only use embryos that would 
otherwise be discarded instead of creating new embryos for research.62 
A few months later, in October 2007, Korea passed an Amendment to 
the Executive Ordinance of the Bioethics Act (“Amendment”).63  Among 
other procedural changes, the Amendment describes the process to call the 
Council of National Bioethics Committee into action and the process to 
create new committees for particular areas of bioethics.64  With regard to 
embryonic stem cell research, the Amendment lists the parts of an embryo 
research plan that require approval before they can be changed.65  These 
parts include changes in the purpose of embryological research, the time 
span of the research, and the number of embryos used.66  Article 12(2) of the 
Amendment limits the permitted sources of eggs used for somatic cell 
nucleus transplantation.67  These procedural amendments, however, do not 
address the major shortcomings of the Bioethics Act.  Primarily, the 
amendments do not address the Act’s failure to require voluntary informed 
consent to ensure that an egg donor understands her role in the research.  
Also, they do not address the Act’s failure to adequately protect human 
embryos from undue harm.  Another amendment with more extensive 
changes to the Bioethics Act has already been submitted to the Korean 
National Assembly.68 
                                           
59
 Tae-gyu, supra note 16. 
60
 Id. 
61
 Id. 
62
 Kim Yoon-mi, Panel Approves Limited Research on Stem Cells, KOREA HERALD, Mar. 24, 2007. 
63
 Enforcement Ordinance of Bioethics and Biosafety Act, Executive Order No. 20316, partly 
amended Oct. 4, 2007, available at http://likms.assembly.go.kr/law/jsp/Law.jsp?WORK_TYPE= 
LAW_BON&LAW_ID=B3684&PROM_NO=20316&PROM_DT=20071004& (unofficial translation on 
file with author) [hereinafter Enforcement Ordinance]. 
64
 Id. arts. 2, 3. 
65
 Id. art. 12. 
66
 Id. 
67
 Id. art. 12(2). 
68
 E-mail from Dr. Young-Mo Koo, Assistant Professor, University of Ulsan College of Medicine 
Asan Medical Center to author (Dec. 4, 2007, 20:50 PST) (on file with author).  Specific information about 
JUNE 2008           FAILURE OF THE SOUTH KOREAN BIOETHICS AND BIOSAFETY ACT 715 
  
III. THE BIOETHICS ACT DOES NOT ADEQUATELY MEET INTERNATIONAL 
STANDARDS FOR PROTECTING EGG DONORS IN EMBRYONIC RESEARCH 
Although the Bioethics Act addresses egg donations made by women, 
it does not have enough safeguards to protect egg donors from exploitation.  
Women may be motivated by altruistic intent to further scientific research 
when they donate their eggs.69  However, it is equally plausible, if not more 
so, that egg donors are pressured into donating their eggs,70 especially in 
Korea where egg donors receive no financial benefit from the donation or 
compensation for the trouble of donating their eggs.71  Due to the absence of 
monetary incentive to donate, many women may not willingly donate their 
eggs, creating a situation where scientists are forced to procure eggs through 
unethical or illegal means.72  Recognizing the need to protect these egg 
donors, the Bioethics Act requires researchers to obtain written consent from 
the donors before using their eggs in research.73  International standards, 
however, have more stringent guidelines that govern research on human 
subjects, such as the requirement that research participants understand the 
aim and scope of the research study, and give their informed and voluntary 
consent.74  Korea’s Bioethics Act falls short of the international standards 
because it does not have adequate protections for women who donate their 
eggs for stem cell research. 
A. International Standards Governing Research on Human Subjects 
Apply to Women Egg Donors 
The Nuremberg Code and the World Medical Association’s 
Declaration of Helsinki are the foremost authorities on human subject 
research.75  The International Bioethics Committee (“IBC”), which advises 
                                                                                                                              
the changes is very limited, in English as well as in Korean.  The Assembly is expected to make a decision 
on the amendment later this year.  Id. 
69
 See Human Fertilisation & Embryology Authority, Donor Motivation in the UK, 
http://www.hfea.gov.uk/docs/donor_motivation_literature_review.pdf (last visited Feb. 17, 2008). 
70
 For a discussion of women being forced to donate their eggs, see infra Part III.B. 
71
 Bioethics Act, supra note 6, art. 13. 
72
 See infra Part III.B. 
73
 See Bioethics Act, supra note 6, arts. 5, 9, 15. 
74
 See infra Part III.B. 
75
 See Bernard A. Fischer IV, A Summary of Important Documents in the Field of Research Ethics, 
32 SCHIZOPHRENIA BULL. 69, 69-70 (2006); see also World Medical Association, Declaration of Helsinki: 
Ethical Principles for Medical Research Involving Human Subjects (1964) (amended in 2000 and clarified 
in 2002 and 2004), available at http://www.wma.net/e/policy/pdf/17c.pdf [hereinafter Declaration of 
Helsinki]; 2 TRIALS OF WAR CRIMINALS BEFORE THE NUREMBERG MILITARY TRIBUNALS UNDER CONTROL 
COUNCIL LAW NO. 10 181-82 (U.S. Govt. Printing Office, 1949), reprinted in Office of Human Subjects 
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the United Nations Educational, Scientific and Cultural Organization 
(“UNESCO”) on ethics in science and technology, has issued a report on the 
necessity and quality of consent obtained from research participants.76  The 
World Health Organization (“WHO”) incorporated the requirements for 
ethical review established in the above-mentioned international guidelines 
and issued the Operational Guidelines for Ethics Committees that Review 
Biomedical Research.77  Though many of these standards are not binding, 
they are aspirational standards, and are widely accepted in the world.78 
Most national as well as international regulations treat women who 
donate their eggs for scientific research as research subjects.  Under the 
Declaration of Helsinki, for instance, biomedical research involving human 
participants includes research on “identifiable human material and data.”79  
Similarly in the United States, under the federal regulations, persons who 
provide biological materials for research are research subjects.80  Women 
who donate eggs for embryonic stem cell research donate human biological 
material, i.e. their eggs, for research.  Thus, the women who donate eggs for 
stem cell research should be characterized and treated as “research 
participants.”81  This classification is important because the Declaration of 
Helsinki applies to “human subjects”82 involved in medical research; if 
women who donate their eggs for scientific research are considered human 
                                                                                                                              
Research, Nuremberg Code, http://ohsr.od.nih.gov/guidelines/nuremberg.html (last visited Apr. 26, 2008) 
[hereinafter Nuremberg Code]. 
76
 See U.N. Educ., Sci. and Cultural Org. [UNESCO], International Bioethics Committee, Report of 
the International Bioethics Committee of UNESCO (IBC) on Consent, SHS/EST/CIB-13/06/CONF.505/2 
Rev 2 (May 19, 2007) [hereinafter UNESCO International Bioethics Committee]. 
77
 World Health Organization [WHO], Operational Guidelines for Ethics Committees that Review 
Biomedical Research, at v, TDR/PRD/ETHICS/2000.1 (2000), available at http://www.who.int/tdr/ 
publications/publications/pdf/ethics.pdf [hereinafter WHO Operational Guidelines]. 
78
 See Bryan Christie, Doctors Revise Declaration of Helsinki, 321 BMJ 913, 913 (2000), 
http://www.bmj.com/cgi/reprint/321/7266/913 (last visited Feb. 17, 2008); see International Compilation of 
Human Research Protections, Office of Human Research Protections, U.S. Dept. of Health & Human 
Services 4 (2008), available at http://www.hhs.gov/ohrp/international/HSPCompilation.pdf.  The United 
States National Institutes of Health has recognized the Nuremberg Code and the Declaration of Helsinki as 
forming the legal foundation for its policies and procedures governing research on human participants.  
U.S. Dept. of Health & Human Services, Guidelines for the Conduct of Research Involving Human 
Subjects at the National Institutes of Health 15 (Aug. 2004), http://ohsr.od.nih.gov/guidelines/ 
GrayBooklet82404.pdf (last visited Apr. 26, 2008) [hereinafter Guidelines for the Conduct of Research 
Involving Human Subjects].  The Korean Medical Association is a member of the World Medical 
Organization.  World Medical Association, WMA Medical Ethics Manual, http://www.wma.net/e/ 
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research subjects, then the protections of the Declaration of Helsinki must 
apply to them as well. 
B. The Bioethics Act Does Not Have Enough Safeguards to Protect 
Women Who Donate Their Eggs for Embryonic Stem Cell Research 
With the worldwide acceptance of the Declaration of Helsinki,83 
informed consent has become a must-have requirement in the field of 
biomedical research.84  As the international guidelines point out, it is equally 
important to ensure that the research subjects are participating in research 
voluntarily.85  To that end, Korea joined other nations in implementing ways 
to protect human research subjects from exploitation, such as by establishing 
the IRB review system.86  However, women who donate their eggs for stem 
cell research are not adequately protected from possible exploitation because 
the Bioethics Act falls short of fulfilling international mandates designed to 
ensure voluntary and uncoerced consent.  Although the Bioethics Act 
contains provisions that lay out the information that should be included in 
the consent form, it does not require that egg donors actually understand the 
purpose of the research being conducted or appreciate the risks involved.  
The IRBs set up by the Bioethics Act have the responsibility of ensuring that 
embryonic stem cell research is conducted ethically,87 but the administration 
of IRBs under the Bioethics Act makes it difficult for the IRBs to conduct an 
independent and unbiased review of the research study. 
1. Because Egg Donors Derive No Personal Benefit from the Research, 
Scientists May Unduly Influence Them to Donate Their Eggs 
The Bioethics Act expressly prohibits any financial reward in 
exchange for egg donations.88  Paying women money in exchange for their 
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eggs may unduly influence them into becoming donors.89  Still, given that 
egg donation is an arduous process which exposes donors to several different 
types of risks ranging from infertility to cancer,90 some bioethicists argue 
that egg donors should be compensated on the basis of time and discomfort 
associated with the egg donation process.91  The Bioethics Act, however, 
does not even allow women to get reimbursed for their time, pain and 
suffering in donating eggs, or for medical treatments for complications 
resulting from these procedures.92  Furthermore, at the present time no 
successful treatment exists that utilizes embryonic stem cells.93  Even if a 
cure for the disease being researched is developed using a woman’s eggs, 
she may not be able to afford the treatment, especially if she is from a lower 
socio-economic class.94 
With no monetary or medical benefit from the donation, it is possible 
that many women will have no incentive or motivation to go through the 
trouble of donating their eggs.  If there are not enough egg donors available, 
scientists involved in embryonic stem cell research may have to secretly pay 
donors or engage in other “problematic practices” to get the required eggs 
for research.95  This has already happened in Korea where investigations 
during the Hwang scandal revealed that Professor Hwang had engaged in 
unethical practices and had unduly influenced women to obtain their eggs 
for research.96 
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Professor Hwang had paid women money in exchange for their eggs.97  
Between November 2002 and December 2005, Professor Hwang’s 
laboratory had monetarily compensated more than ninety-seven women for 
their egg donations.98  The Bioethics Act expressly prohibits any “financial 
reward” in exchange for eggs.99  Any payments for egg donations made after 
January 2005 violated the Bioethics Act.100  Professor Hwang had also 
obtained eggs from junior scientists in his laboratory, which, according to 
some commentators, constituted coercion.101  As one critic points out, “in the 
strict hierarchy of a scientific laboratory in a Confucian society like South 
Korea, junior members often feel great pressure to please their superiors.”102  
In fact, one researcher from Professor Hwang’s laboratory who had donated 
her eggs later wrote in an email, “I shouldn't have done it this way, not 
giving up [my position in the research team] until the end, not fighting 
against the professor.”103  In light of the Hwang scandal and the very real 
possibility that Korean women may feel pressured or coerced into donating 
their eggs, it is important that egg donors are adequately protected from 
exploitation. 
2. The Bioethics Act Does Not Require that Egg Donations Be Made 
Voluntarily and Free of Coercion 
Before allowing research on human subjects, international standards 
require that research participants give voluntary and informed consent to 
participate in the research.104  Informed consent and voluntary consent are 
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two distinct requirements.105  Informed consent deals with the physician or 
researcher’s duty to provide adequate information to the patient or research 
subject. Voluntariness of consent deals with the patient’s decision-making 
ability to give free consent to participate.106  Recognizing this difference, 
international guidelines require informed as well as voluntary consent from 
human subjects involved in the research.  For instance, the Nuremberg Code 
requires that, along with being fully informed of the extent of their 
involvement in research, human research participants should be in a position 
to “exercise free power of choice” to participate.107  Similarly, the 
Declaration of Helsinki requires physicians to pay special attention to 
vulnerable research participants who might be “subject to giving consent 
under duress” or “who will not benefit personally from the research.”108 
The Bioethics Act does not require that the consent obtained from 
research participants be voluntary.  Unlike the Guidelines for Korean Good 
Clinical Practice which require physicians to pay special attention to trials 
involving vulnerable subjects—those who may be unduly influenced by 
expectation of benefits, or those who may be afraid to refuse consent due to 
a retaliatory response from a senior member109—Article 5 of the Bioethics 
Act only guarantees a research participant the right to “consent, or refuse 
consent” to participate in the research after being “fully informed” of his or 
her involvement.110  It is true that the Bioethics Act allows egg donors to 
withdraw their consent,111 but withdrawal of consent is only meaningful if 
the Bioethics Act requires voluntary consent in the first place. 
Because the Bioethics Act does not require women to voluntarily 
consent to egg donations, it does not protect women from the various 
sources of duress that may force them to donate their eggs.  By expressly 
prohibiting any sort of monetary compensation for egg donations, the 
Bioethics Act tries to ensure that women are not swayed to donate their eggs 
because of money.  As commentators have pointed out, however, payment 
for eggs is only one of many ways women donors can be unduly influenced 
into donating their eggs.112  Societal and familial pressures and the 
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authoritative presence of someone in a hierarchy are other causes of duress 
and coercion that may make a woman’s consent to donate involuntary.113 
The Bioethics Act, however, is quiet on these other possible sources of 
duress.  For example, it is not clear whether egg donations made by junior 
researchers in Professor Hwang’s laboratory would have constituted 
coercion under the Bioethics Act,114 even though the donations undoubtedly 
violated the Declaration of Helsinki115 which states that “special attention is 
also required for those who cannot give or refuse consent for themselves, for 
those who may be subject to giving consent under duress.”116  The Bioethics 
Act’s silence on the issue of voluntary consent highlights its failure to 
protect vulnerable subjects who might not be in a situation to deny consent 
to stem cell research participation.117  By addressing only monetary 
compensation as a potential form of duress and by not expressly requiring 
that a woman voluntarily consent to donate her eggs, the Bioethics Act falls 
short of the international guidelines and fails to adequately protect the 
autonomy of egg donors. 
3. The Bioethics Act Violates International Standards by Not Requiring 
that Egg Donors Understand the Research and Associated Risks 
The International Bioethics Committee states that “it is necessary [in 
scientific research] to make the [research subject] aware of the aim of the 
research, the methodology and the duration, expected benefits for him/her or 
for other persons concerned and the risks involved.”118  As a member state of 
UNESCO,119 Korea is expected to follow the guidelines set forth by the 
International Bioethics Committee. 
The Korean Bioethics Act does not require researchers to inform the 
research subjects of the potential risks involved in the research study.  The 
Bioethics Act only mandates that the written consent form state the purpose 
of producing an embryo, details regarding the storage and disposal of 
                                           
113
 Russell Korobkin, Buying and Selling Human Tissues for Stem Cell Research, 49 ARIZ. L. REV. 
45, 53 (2007). 
114
 See generally Bioethics Act, supra note 6 (denying financial reward for donating oocytes, but not 
protecting an egg donor from other possible sources of coercion or undue influence). 
115
 See Han, supra note 97, at 23; Hwang Admits In-House Egg Donations, KOREA TIMES, Nov. 25, 
2005. 
116
 Declaration of Helsinki, supra note 75, ¶ 8. 
117
 The Guidelines for Korean Good Clinical Practice do not apply to protect the women who donate 
their eggs for embryonic stem cell research because the Guidelines are not laws and the Bioethics Act states 
that only “other laws concerning bioethics” may be relied upon.  Bioethics Act, supra note 6, art. 3. 
118
 UNESCO International Committee of Bioethics, supra note 76, ¶ 13. 
119
 UNESCO, Member States, http://erc.unesco.org/cp/MSList_alpha.asp?lg=E (last visited Feb. 20, 
2008). 
722 PACIFIC RIM LAW & POLICY JOURNAL VOL. 17 NO. 3 
 
 
embryos, whether remaining embryos can be used for purposes other than 
pregnancy, information about the procedures for withdrawal of consent, and 
other information regarding consenters' rights or any other information the 
MHW finds necessary.120  The Act’s inherent vagueness as to what 
constitutes “other necessary information”121 is compounded by the Act’s 
failure to require scientists to disclose information about “expected benefits” 
of the research and the “risks involved” as required by UNESCO 
guidelines.122 
After a full disclosure of expected benefits and potential risks of a 
particular research study, the international standards place a further burden 
on researchers and physicians.  The Declaration of Helsinki requires that 
research subjects understand the information presented to them by the 
physician.123  Thus, scientists can only utilize a subject in a research study 
after a full disclosure of expected benefits and risks involved and after 
making sure that the subject understands the information presented to him or 
her.  The Korean Bioethics Act does not require that research subjects 
understand the information presented to them before allowing them to 
participate in stem cell research. 
“Embryo producing medical institutions,” facilities that “collect 
sperms or oocytes in order to produce an embryo,” are required under the 
Bioethics Act to “explain in detail the contents of [the consent form to the 
oocyte donors] before obtaining a written consent.”124  Requiring a signed, 
written consent from oocyte donors is an important first step in ensuring that 
research subjects are not exploited.  However, as one commentator points 
out, compliance with research ethics should move away from “checking off 
boxes” and towards a “culture of conscience.”125  The use of “readability 
tests” and other measures to ensure that the consent form uses simple words 
and sentences such that a woman with little formal education can understand 
it is one way of creating that culture of conscience.126  Instead of the 
researcher providing large amounts of complicated information to egg 
donors, it might be helpful to have a counselor present at the meetings who 
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uses visual aids to explain the contents of the consent form.127  Egg donors 
may feel more comfortable asking the counselor questions regarding the 
research and stating their unwillingness to participate.  Moreover, the 
counselor likely has more experience than a scientist in communicating 
information.  The Bioethics Act lacks “conscience” because it takes no steps 
to ensure that only women who truly understand the manifold risks of 
donating their eggs are allowed to donate eggs. 
The text of the Bioethics Act also warrants the requirement of 
comprehension of the information presented to research participants.  
Allowing scientists to conduct research when a research subject fails to 
understand the “aims, [and] methods” of the study contradicts the purpose of 
the Bioethics Act.128  The Bioethics Act aims to “protect human dignity and 
to prevent harm to human beings.”129  How can the Bioethics Act prevent 
harm to human beings if it does not require that the human subjects who 
volunteer to participate in a research study actually understand the potential 
risks and harms arising from the research?  For instance, a woman may 
decide to go to an embryo producing medical institution to donate her eggs 
to embryonic stem cell research thinking that the procedure will not be any 
different from donating blood.  To prevent unnecessary harm to egg donors, 
it is important that the woman understand all the risks associated with 
donating eggs, risks that include Ovarian Hyperstimulation Syndrome, 
future infertility, and cancer.130  It is only after a woman understands and 
appreciates the risks involved in donating eggs and the purpose of the 
research study that she can give a truly informed and voluntary consent. 
The dangers present when a research subject does not understand the 
purpose of the research are heightened in embryonic stem cell research.  
Women who donate eggs entirely for research purposes are not seeking any 
personal medical or reproductive benefit from the donation, but are taking 
risks for the potential benefit to others and may be mistaken about the use of 
the resulting embryo.131  Therapeutic misconception has been pointed out as 
a real and significant danger of embryonic stem cell research.132  A 
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description of the potential uses of stem cells along with reasons why stem 
cell research is so promising can make it confusing for the donor to 
understand that there are no “embryonic stem-cell based therapies currently 
available.”133  Egg donors must understand the nature of embryonic stem cell 
research so they can make an informed decision about whether they want to 
become research subjects.  The Bioethics Act “aims to prevent harm to 
human beings,”134 which includes preventing harm to egg donors.  Requiring 
that egg donors actually understand the research, its goals, and inherent risks 
in donating their eggs is an internationally accepted way of preventing this 
type of harm. 
4. The Bioethics Act Fails to Heed WHO’s Guidelines that Require IRBs 
to Function Independently of the Research Institution 
International organizations have recognized the importance of having 
ethics committees that review research that is conducted on human subjects.  
The Declaration of Helsinki requires that the protocol of research involving 
human subjects “should be submitted for consideration, comment, guidance, 
and where appropriate, approval to a[n] [independent] specially appointed 
ethical review committee.”135  It further states that the researcher should 
submit and the committee should review “information regarding funding, 
sponsors, institutional affiliations, other potential conflicts of interest and 
incentives for subjects.”136  WHO has also published the Operational 
Guidelines for Ethics Committees That Review Biomedical Research.137  
These guidelines establish “an international standard for ensuring quality in 
ethical review” of biomedical research.138 
Recognizing the international importance of having ethics committees 
review biomedical research, Korea enacted the Korean Good Clinical 
Practice (“KGCP”) in 1995.139  In January 2001, the Korean government 
revised the KGCP based on the International Conference on Harmonization 
of Good Clinical Practice, an international ethics guideline for clinical 
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trials.140  This revision required that legal and institutional bases be 
established to ensure that the constitution and operation of IRBs are 
standardized and upgraded to international levels.141  In March 2002, IRB 
members in major hospitals, biomedical researchers, medical directors of 
pharmaceutical companies and officers from health authorities founded the 
Korean Association of Institutional Review Boards (“KAIRB”) under the 
auspices of the Korean Academy of Medical Sciences.142  The main mission 
of the KAIRB is to help Korean IRBs build up ethical review capacity to the 
international level.143 
Against this backdrop, the Korean Bioethics Act stipulates that every 
embryo research institution set up its own IRB.144  The law describes the 
organization and administration of IRBs145 and lays out their role in 
reviewing biomedical research.  However, the Bioethics Act falls short of 
international standards, particularly the WHO Operational Guidelines, 
because it does not require that the IRB act independently of the research 
institution. 
International standards guiding the organization and functioning of 
ethics committees are much more stringent than the Korean Bioethics Act.  
WHO Operational Guidelines require a member of the ethics committee to 
“withdraw from the meeting for the decision procedure concerning an 
application where there arises a conflict of interest.”146  “Conflict of interest” 
exists when a board member has “financial, material, institutional, or social 
ties to the research” or there are other factors present that may “jeopardize 
his/her (their) ability to provide a free and independent evaluation of the 
research focused on the protection of the research participants.”147 
Compared to the WHO Guidelines, the Bioethics Act takes a narrower 
approach to determine when an IRB member may be ineligible to participate 
in the review process.  Article 10 of the Bioethics Act states that each IRB 
will be made up of five to nine people, and will include one person who is 
“not engaged in the fields of life science or medical science, as well as one 
person [who is] external to the institution.”148  Members who are “involved 
in research, development, or utilization of life sciences and biotechnologies” 
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that are being reviewed by the Board are barred from participating in the 
review process.149 
The Bioethics Act does not define what it means by the phrase 
“involved in research, development, or utilization” of biotechnology.  
Webster’s Dictionary defines the verb “involve” as “to engage as a 
participant.”150  So the Bioethics Act bars participants of embryological stem 
cell research from being on the committee that reviews the research.  Even 
though “involved” can cover a broad range of relationships that might be 
problematic to a fair assessment of biomedical research, the use of the 
phrase “in research, development, or utilization of life sciences and 
biotechnologies” restricts its reach.  Only members who have a scientific, 
institutional or financial interest in the research or utilization of a 
biotechnology can be said to be “involved” so as to bar them from 
participating in the review process.  Members who are not “involved” in the 
research, development, or utilization of the technology, but have other 
“social ties”151 with the research or development of the biotechnology would 
not be barred under the Bioethics Act from being on the IRB that reviews the 
research protocol.152  The international guidelines, however, explicitly 
prohibit an ethics committee member from having any “social ties” or any 
other relationship that might jeopardize their decision-making ability from 
being on the review board.153  For example, some of the members of the IRB 
that reviewed Professor Hwang’s research were alleged to have been 
originally nominated by Professor Hwang’s team.154  Under the international 
guidelines, this social relationship between Professor Hwang and the IRB 
members he nominated would prevent those members from reviewing his 
research.  However, under the Bioethics Act, the members were allowed to 
review Professor Hwang’s research because they were not “involved” in the 
study.  International standards ensure that a research proposal or protocol 
will face an independent review process, whereas there is no such guarantee 
under the Bioethics Act in Korea. 
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IV. THE KOREAN BIOETHICS ACT FAILS TO SUGGEST AN APPROPRIATE 
TIMEFRAME TO USE HUMAN EMBRYOS IN SCIENTIFIC RESEARCH 
Embryonic stem cell research raises important questions about the use 
of human embryos in scientific research.155  On the one hand, embryonic 
stem cell research has the potential to cure diseases such as Alzheimer’s and 
Parkinson’s and treat conditions like spinal cord injury, heart disease, and 
diabetes.156  On the other hand, the process of deriving stem cells from an 
embryo results in the embryo’s destruction.157  Ethics committees around the 
world, including in Korea, are struggling to determine the moral and legal 
status of human embryos that are used in stem cell research.158  If an embryo 
is a potential human being, should it be granted all the protections that a 
human being enjoys?  Any country that allows stem cell research to be 
conducted on human embryos should answer this question and justify the 
improvement in human health that results from the destruction of potential 
human beings.  Unfortunately, the Korean Bioethics Act fails to do just that 
due to its inability to adequately protect human embryos from unnecessary 
destruction. 
A. International Guidelines Require Special Attention Be Paid to the Use 
of Human Embryos in Scientific Research 
International guidelines carefully regulate the use of human embryos 
in scientific research.  Research involving human subjects includes “research 
on identifiable human material” under the Declaration of Helsinki.159  This 
provision applies to identifiable human tissue, which includes human 
embryos.160  This interpretation is consistent with the intent of the World 
Medical Association (“WMA”) to extend the Declaration of Helsinki to 
human embryos as indicated in WMA Statement on In-Vitro Fertilization 
and Embryo Transplantation, which states that the Declaration of Helsinki 
will apply to “all clinical research in respect to . . . embryo 
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transplantation.”161  Thus a human embryo is considered a “human subject” 
under the Declaration of Helsinki, making it eligible for a “careful 
assessment of predictable risks and burdens in comparison with foreseeable 
benefits” to the embryo before allowing research.162  In fact, the WMA’s 
Statement on Assisted Reproductive Technologies expressly states that 
“research [on human embryos] should be carefully controlled and should be 
limited to areas in which the use of alternative materials will not provide an 
adequate alternative.”163  It also emphasizes the need to handle and 
manipulate human embryos in a manner that would “protect [them] from 
abuse.”164 
Many countries have closely traced the language of the Declaration of 
Helsinki and the WMA statements in laws that regulate research on human 
embryos.  For instance, in Australia, before the Human Research Ethics 
Committee approves any proposal that involves research on human embryos, 
it must be satisfied that “the likely benefits of the proposed research cannot 
be achieved without using human embryos,” and the potential benefit of the 
proposed research is enough and justifiable to allow harm to human 
embryos.165  Similarly, the Singapore Bioethics Advisory Committee 
recognizes that “a human embryo has a special status as a potential human 
being” which is distinct from a living human being.166  Like Australia, 
Singapore also utilizes a balancing of respect to the embryo with the benefits 
arising from proposed research.167  The greater the promised medical benefit 
of the proposed research, the more likely that the Singapore Bioethics 
Committee would permit embryonic research. 
The need to protect human embryos used in scientific experiments has 
been interpreted as a focus on the importance of the research goals and the 
way embryos are handled in research, instead of whether embryos may be 
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destroyed.168  Thus, for example, the Warnock Report in the United 
Kingdom prohibits “frivolous or unnecessary” use of human embryos in 
scientific research.169  The international guidelines prohibiting misuse of 
human beings for research purposes are applied to human embryos in the 
United States as well.170 
B. The Bioethics Act Lacks the Language Necessary to Ensure 
Appropriate Use of Human Embryos in Stem Cell Research 
The Bioethics Act does contain some restrictions on the use of human 
embryos in stem cell research, but these limitations are not adequate.  The 
Bioethics Act prohibits reproductive cloning,171 while allowing therapeutic 
cloning of embryos.172  Furthermore, any research on human embryos has to 
be performed before “the embryological primitive streaks appear in their 
developmental process.”173  In contrast to research on other human cells and 
tissues, any research involving human embryos must occur for one of the 
three enumerated purposes.174  The research must be aimed at 1) developing 
“contraception and infertility treatments,” 2) “curing rare or incurable 
diseases,” or 3) any other research approved by the President.175  
Researchers are also required to follow specific guidelines regarding the 
storage, usage, and disposal of embryos.176 
The above-mentioned safeguards put in place by the Bioethics Act to 
ensure proper use of human embryos in scientific research fall short of 
international standards.  International standards require that stringent 
conditions be met before human embryos can be used in scientific 
research.177  Yet the Korean Bioethics Act has no provisions that provide 
guidance as to when it would be appropriate to use embryos in stem cell 
research.  Nowhere in the Bioethics Act does it require that, where possible, 
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researchers should use alternatives to human embryos as required by the 
WMA Statement on Assisted Reproductive Technologies.178  The Bioethics 
Act allows NBC and the President to approve any research on human 
embryos.179  The Bioethics Act fails to give effect to the Helsinki 
Declaration because it contains no provision requiring NBC or the President 
to weigh the risks of embryonic research against foreseeable benefits before 
approving the research under Article 17 of the Bioethics Act.180  The 
Bioethics Act’s silence on what constitutes appropriate use of human 
embryos for research contradicts the explicit requirements of the 
international standards. 
V. KOREA SHOULD AMEND THE BIOETHICS ACT TO MAKE IT COMPATIBLE 
WITH INTERNATIONAL STANDARDS 
Advances in biotechnology must be balanced against the legal and 
ethical risks to research subjects.  The Bioethics Act should include 
mechanisms to ensure the adequacy and quality of informed consent 
received from egg donors, to review the circumstances under which 
informed consent is obtained, and to determine the ability of IRBs to 
effectively perform their role.  It should also include provisions promoting 
alternatives to the use and destruction of human embryos.  As Korea is 
considering amending its Bioethics Act, it can incorporate the aspects of 
international protections that would work in Korea to protect research 
subjects while advancing scientific research and development. 
In August 2005, the Director of the Bioethics Policy Division of the 
MHW issued a statement claiming that South Korea has “concrete and 
comprehensive regulations on the scope of embryo research.”181  The 
Director pointed to the Bioethics Act to demonstrate that human embryo 
production and research is strictly regulated and written consent is required 
from sperm and oocyte donors.182  The position of the Korean government 
changed in 2006, after the Hwang scandal became public knowledge.  Since 
then, several different governmental organizations and entities have 
expressly stated the need for the government to “step up its efforts to assure 
proper ethical research standards” and “establish a scrupulous system for 
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donating human eggs for research purposes.”183  To that end, Korea should 
amend the Bioethics Act to ensure that higher ethical standards of scientific 
research are upheld in embryonic stem cell research. 
A. The Bioethics Act Should Require IRBs to Ensure that the Informed 
Consent Obtained from Egg Donors Is Voluntary 
Korea should incorporate adequate and effective ways to monitor the 
circumstances under which women are giving consent to donate eggs.  One 
such way could be for the Korean Act to explicitly require researchers to 
obtain voluntary consent that is not obtained by coercion, undue influence or 
duress.  The IRB should have the responsibility to make sure that women are 
not coerced into donating eggs due to their dependent status, monetary 
inducements, or their “compromised ability to offer fully voluntary 
consent.”184  IRB members could interview women donors to determine their 
motives in donating eggs and the circumstances in which they agree to 
donate.185  An independent counselor not involved in the research project 
could also counsel egg donors on the various aspects of egg donation.186 
Other amendments could include placing a maximum limit on the 
number of times a woman can donate eggs for research187 and prohibiting 
women working in the lab from donating their eggs.188  Furthermore, the 
Bioethics Act should require that women donors actually understand the 
research in which they are participating and truly appreciate the risks 
involved in donating eggs.  The IRB should review the “adequacy, 
completeness, and understandability of written and oral information”189 that 
is given to egg donors.  Inclusion of a requirement that women undertand all 
the information that is presented to them is the first step in the right 
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direction—upholding and protecting their dignity.  Where human research 
subjects are involved, the highest degree of ethics must be applied. 
B. The Bioethics Act Should Include Provisions Assuring the Proper Use 
of Human Embryos in Stem Cell Research 
Korea should follow Australia and Singapore’s approach to regulating 
embryonic stem cell research to ensure that human embryos are not 
unnecessarily harmed.190  The Bioethics Act should require MHW to weigh 
the potential benefits of a proposed research against the harm done to the 
embryos before approving any research on stem cells that are derived from 
human embryos.  Following Singapore’s approach, the Korean Bioethics Act 
could also require scientists to draw embryonic stem cells from existing stem 
cell lines before destroying more embryos to get stem cells.191 
The Bioethics Act should also seek to promote technology that does 
not destroy human embryos.  The Act already allows research on adult stem 
cells.192  Adult stem cells are found in the tissues of a grown human being.193  
Derivation of adult stem cells does not harm the person from whom those 
cells are derived; neither does it harm an embryo.194  Thus, instead of merely 
giving the national and regional governments an option of supporting 
research on adult stem cells, the Korean government should actively support 
research on adult stem cells.  This is even more important in light of the fact 
that the benefits of embryonic stem cells are speculative, but adult stem cells 
have already been successfully used in numerous patients to allow them to 
regrow damaged tissues.195 
Finally, the Korean Bioethics Act should include provisions that 
provide an incentive for scientists to engage in researching new 
biotechnologies.  In late 2007, scientists were able to transform human skin 
cells into stem cells.196  Then, in January of 2008, an Australian scientist was 
able to extract a single cell from an embryo, a technique which did not 
negatively affect the future development of the embryo.197  Korea should 
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invest money in and actively promote these approaches and the development 
of additional alternatives to destroying embryos to get stem cells. 
VI. CONCLUSION 
In recent years, Korea has continued to invest money and resources in 
embryonic stem cell research.  Embryonic stem cell research poses unique 
challenges because egg donors and human embryos are harmed during a 
research study from which they do not receive any direct benefit.  As it 
currently stands, the Bioethics Act is inadequate to protect women who 
donate their eggs for stem cell research because the Act does not require that 
women consent to the donation voluntarily and free of any undue influence.  
The Bioethics Act also does not require that the egg donors understand the 
research in which they are participating and its associated risks.  Moreover, 
the Bioethics Act falls short of international standards because it does not 
limit the use of human embryos in scientific research. 
To strengthen its protections of women and embryos, Korea’s 
Bioethics Act should look to international standards and incorporate 
requirements that would protect women and embryos from being exploited.  
The Bioethics Act should require that egg donors understand the purpose of 
the research study and its associated risks before giving their voluntary 
consent.  In addition, the Act should promote research that does not require 
the destruction of human embryos to obtain stem cells.  Bringing the 
Bioethics Act into greater conformity with international standards will assure 
that Korea takes an ethical approach to embryonic stem cell research and 
will make it possible for Korea to fulfill the stated aims of the Bioethics Act 
while staying ahead in stem cell research. 
